1. BRAF V600E mutations in patients with papillary thyroid cancer is associated with an increase in mortality.
2. Despite an association, BRAF V600E does not appear to add prognostic information after adjusting for clinical and histopathological features of the tumor.
Study Rundown: While this retrospective study observed a significant association...